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Chronic Cadmium Exposure Stimulates SDF-1 Expression
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Abstract
Cadmium is an omnipotent environmental contaminant associated with the development of breast cancer. Studies suggest
that cadmium functions as an endocrine disruptor, mimicking the actions of estrogen in breast cancer cells and activating
the receptor to promote cell growth. Although acute cadmium exposure is known to promote estrogen receptor-mediated
gene expression associated with growth, the consequence of chronic cadmium exposure is unclear. Since heavy metals are
known to bioaccumulate, it is necessary to understand the effects of prolonged cadmium exposure. This study aims to
investigate the effects of chronic cadmium exposure on breast cancer progression. A MCF7 breast cancer cell line
chronically exposed to 1027 M CdCl2 serves as our model system. Data suggest that prolonged cadmium exposures result in
the development of more aggressive cancer phenotypes – increased cell growth, migration and invasion. The results from
this study show for the first time that chronic cadmium exposure stimulates the expression of SDF-1 by altering the
molecular interactions between ERa, c-jun and c-fos. This study provides a mechanistic link between chronic cadmium
exposure and ERa and demonstrates that prolonged, low-level cadmium exposure contributes to breast cancer progression.
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Introduction
Breast cancer is one of the most common malignancies afflicting
women in the United States, and it has the second highest
mortality rate associated with any cancer. The majority of breast
cancers initially develop as hormone-dependent, with estrogen
receptors expressed in approximately 70% of breast cancer cases.
The presence or absence of ERa is a key determinant of the
prognosis of the disease, in addition to determining whether the
cancer will respond to hormone therapy or not. ERa-positive
breast cancers are often hormone-responsive and are typically
treated with antiestrogens like tamoxifen. However, hormone-
dependent breast cancer frequently progresses into more malig-
nant cancer phenotypes that are often hormone-independent. In
many cases, the estrogen receptor (ERa) is still present, but the role
of ERa in hormone refractory breast tumorigenesis and its
underlying mechanism are unclear. A potential mechanism
involves metalloestrogens– heavy metals that function as endocrine
disruptors and mimic the actions of estrogen.
Among the metalloestrogens, cadmium is the best character-
ized. Cadmium is derived from various industrial sources,
including present and former mining activities, production of
alloys, batteries, fertilizers, pigments, and combustion by-products.
Human exposure results from the consumption of contaminated
water and food or inhalation of cigarette smoke and contaminated
fumes. Cadmium exposure has long been associated with the
development of breast cancer [1–5], but the mechanism of
cadmium’s action on breast cancer remains elusive. Recent studies
have suggested that cadmium may function as an endocrine
disruptor to perturb the normal hormonal cycle and promote
neoplastic growth in the mammary gland [2,4]. Animal studies
have also shown that cadmium exposure can increase the density
of the mammary glands as well as induce changes in the lining of
the uterus, all of which are early signs of hormone-related
tumorigenesis [4,6,7].
Cadmium has also been shown to promote ER-dependent
breast cancer cell proliferation, potentially through the activation
of the ER signaling pathway [3,5,8,9]. Results from our lab and
others have suggested that cells treated with cadmium express
higher levels of ER target genes, including cyclin D1, c-myc,
progesterone receptor, and cathepsin-D [3,5,8]. Although cadmi-
um is known to bind to ERa, the mechanism behind ER-mediated
gene expression and subsequent breast cancer cell growth is not
completely established. Results from our previous study showed
that cadmium promotes the nuclear localization of ERa and
enhances the binding of ERa to target gene promoters [8]. It was
also demonstrated that cadmium potentiates the interaction
between ERa and c-jun, a member of the AP-1 family of
transcription factors.
Although there is a better understanding of how acute cadmium
exposure activates ERa and mediates the expression of genes
associated with cell growth, it is unclear how chronic exposure of
cadmium may affect breast cancer development and/or ER-target
gene expression. Previous studies on prostate cancer and sarcomas
have suggested that chronic exposure to cadmium is associated
with the development of more malignant tumors [10–12].
Furthermore, cadmium has been detected in breast tumor tissues
[1,13–16]. While healthy individuals had measurable cadmium
levels in their mammary glands, significantly higher levels of
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cadmium were found in patients with breast cancer [1,13–16].
The effects of cadmium in these tumors and whether its presence
results in further progression of the disease are unknown,
underscoring the need for chronic exposure studies.
This study aims to investigate the chronic effects of cadmium
exposure on breast cancer progression. We developed a series of
cadmium exposed-breast cancer cell lines to study the effects of
chronic cadmium exposure on breast cancer progression. This
study provides several lines of evidence suggesting that prolonged
cadmium exposure results in more aggressive cancer phenotypes–
increased cell growth, migration and invasion. Our results also
show for the first time that cells chronically exposed to cadmium
express higher levels of SDF-1 in an ERa-dependent manner.
Furthermore, data from this study also suggest that prolonged
cadmium exposure alters the molecular dynamics between ERa
and c-jun/c-fos to mediate direct changes in the expression of
cancer-promoting genes like SDF-1.
Materials and Methods
Cell Culture
MCF7 cells were obtained from the American Type Culture
Collection (ATCC, Manassas, VA). MCF7-Cd was developed by
exposing parental MCF7 cells to 1027 M CdCl2 for over 6
months. Parental MCF7 and MCF7-Cd were maintained in
Dulbecco’s Modified Eagle Medium (DMEM) supplemented with
10% Fetal Bovine Serum (FBS; Hyclone, Logan, UT) and 1%
penicillin and streptomycin (P/S). Both cell lines were subcultured
every 3–4 days.
Growth Assay
1.56105 MCF7 and MCF7-Cd (MCF7-Cd4, Cd7, and Cd12)
cells were plated in six-well plates using hormone depleted media.
Cells were counted in triplicate every 2 days using a cell counter
(Nexcelom Bioscience LLC, Lawerence, MA). Data points
represent three independent experiments.
Derivation of Cadmium Cell Lines
To derive clonal cell lines chronically exposed to cadmium,
MCF7 cells were first exposed to 1027 M CdCl2 for over 6 months
in order to mimic chronic exposures. Chronically exposed cells
were plated on soft agar to allow single cells to develop into
colonies. Briefly, a 1% agar solution made with complete media
(DMEM+10% FBS +1% P/S) was used to create the bottom layer.
Serial dilutions of single cell suspensions were mixed with enough
complete media to make a 0.6% top agar that was added over the
1% bottom agar layer and allowed to solidify for 30 minutes at
room temperature followed by incubation at 37uC. When colonies
sizes reached about 100 cells or more, they were individually
removed from soft agar under aseptic conditions and resuspended
in complete media to permit further expansion.
Scratch Wound Assay
Approximately 2.06104 cells were plated in 6-well plates and
allowed to grow to approximately 75–80% of confluency in
DMEM. A wound or scratch was created with a 200 mL
micropipette tip and washed twice with 1X PBS. Cells were
allowed to migrate for 3 and cells were visualized under 5X
objective with a 10X ocular magnification (with a final magnifi-
cation of 50X). At least three frames of each well were captured
digitally at day 0 and day 3. Images presented in the figures are
representative of three independent experiments done in tripli-
cates.
Migration and Invasion Assay
A modified Boyden chamber assay was used to quantitatively
assess the cells’ migration and invasion abilities. For the migration
assay, cells were hormone-deprived, and 5.06104 cells were
seeded in the upper chamber over polycarbonate membrane
inserts and allowed to migrate toward the lower chamber filled
with DMEM+10% FBS+1% P/S. The cells were incubated for
12–18 hours, fixed in formalin, and stained with crystal violet. The
number of cells that migrated to the underside of the filter was
counted in triplicate. For the invasion assay, a CytoSelectTM Cell
Invasion Assay Kit (Cell Biolabs, Inc, San Diego, CA) was used
according to the manufacturer’s protocol. Briefly, 5.06104
hormone-deprived cells were seeded in the upper chamber and
the cells that invaded through the matrigel were fixed, stained and
counted as previously described.
Western Blot
Cells were lysed in 1% SDS-HEPES buffer and the total protein
concentration was normalized using the Bio-Rad Dc Protein Assay
kit (Bio-Rad, Hercules, CA). Proteins were separated using SDS-
polyacrylamide gel electrophoresis and transferred to polyvinyli-
dene fluoride (PVDF) membranes (Millipore, Billerica, MA).
Protein expression was monitored using protein-specific antibod-
ies: a-ERa (NeoMarkers, Fremont, CA), a-cyclin D1 (Santa Cruz
Biotechnology, Santa Cruz, CA), a-c-myc (Santa Cruz Biotech-
nology), a-cyclin A (Santa Cruz Biotechnology), a-cyclin E (Santa
Cruz Biotechnology), a-cdk2 (Santa Cruz Biotechnology), a-cdk4
(BD Transduction Laboratories, San Jose, CA), a-p21 (Santa Cruz
Biotechnology), a-p-27 (Santa Cruz Biotechnology), a-CDH1
(Santa Cruz Biotechnology), a-b-catenin (Cell Signaling Technol-
ogy, Danvers, MA), a-GAPDH (Cell Signaling Technology).
SDF-1 ELISA
Cells were plated at a density of 16105 cells per well in 6-well
plates. Cell culture media was collected after 48 hours and stromal
cell-derived factor-1 (SDF-1) levels were measured with enzyme-
linked immunosorbent assays (ELISA) SDF-1 kit (RayBiotech, Inc,
Norcross, GA) according to the manufacturer’s instructions.
Briefly, 100 mL of sample was added to 96-well plates containing
immobilized antibodies specific for human SDF-1 and allowed to
incubate overnight with shaking at 4uC. Wells were then washed
and a biotinylated anti-human SDF-1 antibody was added,
followed by another wash and subsequently by the addition of
HRP-conjugated streptavidin. Following a final wash, tetramethyl-
benzidine (TMB) substrate for color development was added and
samples were read at 450 nm after the addition of a stop solution.
siRNA Transfection
16105 cells were plated in 6 well plates and transfected with
siRNA (Santa Cruz Biotechnology) targeting either ERa, c-jun or
c-fos using siRNA transfection reagents (Santa Cruz Biotechnol-
ogy). A scrambled siRNA was transfected as a control. Five hours
after transfection, the medium was changed to DMEM medium
containing 10% FBS and 1% P/S. Cells were harvested 48 hours
later for gene and/or protein expression analysis using semi-
quantitative reverse transcription-polymerase chain reactions (RT-
PCR) or quantitative PCR (qPCR), and Western blot analysis,
respectively.
Reverse Transcriptase Polymerase Chain Reaction (RT-
PCR)
Total RNA was isolated from cells using TRI-Reagent (Zymo
Research Corporation, Irvine, CA) and columns from the Direct-
Chronic Cadmium Exposure Promotes SDF-1 Expression
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zol RNA MiniPrep kit (Zymo Research) according to the
manufacturer’s protocol. Three micrograms (mg) of total RNA
were used for the reverse transcription reaction with oligo-dT18
primers and Moloney Murine Lukemia Reverse Transcriptase (M-
MLV RT, Promega, Madison,WI). Gene expression was moni-
tored using semi-quantitative PCR for 28 cycles. PCR products
were separated by agarose gel electrophoresis, and visualized using
Chemi-Doc (Biorad). Gene expression was quantified using gene
specific primers with quantitative real-time PCR with SYBR green
(SA Biosciences, Valencia, CA). All primers were synthesized by
Integrated DNA Technologies, Inc. (IDT; San Diego, CA). RT-
PCR Primer Sequences:











Cells were plated in 10 cm tissue culture plates and harvested 48
hours later. Cells were lysed in 0.5% NP-40 lysis buffer and
sonicated three times for 30 seconds. Cell lysates were immuno-
precipitated with a-ERa, a-c-fos, a-c-jun or normal rabbit IgG
(Santa Cruz Biotechnology) for 2 hours, followed by incubation
with either protein A or G agarose beads for 1 hour. Protein
complexes were separated with SDS-PAGE followed by Western
blot analysis with ERa, c-jun, c-fos, and normal rabbit IgG
antibodies.
Chromatin Immunoprecipitation (ChIP) Assays
Cells were plated in 10 cm plates and harvested by fixation with
formaldehyde. Cells were lysed and sonicated in lysis buffer to
fragment the chromatin into 1–2 kb fragments. Chromatin
mixtures were immunoprecipitated with antibodies specific for
ERa, c-fos, and c-jun. Antibody complexes were purified using
protein-A agarose beads (Pierce, Rockford, IL). After DNA-
protein complexes were reversed cross-linked (65uC for 4–6 hours),
DNA fragments were purified using QIAQuick columns (Qiagen,
Germantown, MD). Occupancy at specific promoters were
determined with PCR using promoter specific primers. For the
re-ChIP assay, the protein A-antibody complexes from the first
ChIP assay were extracted with 200 ml of 10 mM DTT for 30
minutes at 37uC. After the supernatant was diluted 10X with re-
ChIP buffer (20 mM Tris- HCl, pH 8.1, 2 mM EDTA, 150 mM
NaCl, and 0.1% Triton X-100), the chromatin mixture was re-
ChIPed with a second antibody: a-ER, a-c-jun, a-c-fos or normal
rabbit IgG, (Santa Cruz Biotechnology). This step was repeated
one more time for the triple-ChIP assay and the re-ChIPed DNA-
protein complexes were immunoprecipitated with a third antibody
(c-fos or rabbit IgG). Following, the purification of the final
antibody complexes with protein A beads, the DNA was reverse-











The reporter gene assay was performed by sequentially
transfecting MCF7 cells with siRNA targeting ERa (Santa Cruz
Biotechnology) followed by the SDF1 promoter-Luc reporter
plasmid. Five hours after siRNA transfection, the second
transfection with the SDF-1 Luc reporter plasmid along with the
pRL-SV40 Renilla luciferase plasmid (Promega) was accomplished
using Fugene HD (Promega) according to the manufacturer’s
protocol. The medium was changed to DMEM media containing
10% FBS and penicillin and streptomycin, and cells were
harvested 48 hours post-transfection and analyzed using a dual
luciferase assay kit (Promega). All reporter gene assays were
performed in quadruplicate, with the entire experiment repeated
at least three times. SDF-1-Luc was purchased from Genecopoeia
(Rockville, MD).
Results
We previously found that acute cadmium exposures increase
growth rates of three ERa-positive breast cancer cell lines– MCF7,
T47D and ZR75-1– and increase the expression of genes
associated with growth [8]. The observation that acute cadmium
exposure stimulates breast cancer cell proliferation led us to
question the effects of chronic cadmium exposure on breast cancer
progression. To understand how chronic cadmium exposure
affects the progression of ER-positive breast cancer, a cell line
chronically exposed to cadmium was developed by exposing
MCF7 cells to low concentrations of cadmium (1027 M) for over
six months. The growth properties of cells chronically exposed to
cadmium (MCF7-Cd) were analyzed in the presence or absence of
cadmium and compared to parental MCF7 cells. Approximately
1.56104 cells were plated in 6-well plates under hormone-deprived
conditions and treated with 1027 M cadmium chloride (CdCl2) or
mock treated with phosphate buffered saline (PBS). Cell growth
was monitored 2, 4 and 6 days after treatment. The MCF7-Cd
cells displayed a significantly faster growth rate than the parental
MCF7 cells in the presence and absence of cadmium (Fig. 1A).
Metastatic phenotypes including the ability to migrate and
invade through extracellular matrix were also evaluated. The
ability of cells chronically exposed to cadmium to migrate was
analyzed and compared to parental MCF7 cells using a scratch-
wound assay (Fig. 1B). Cells were plated in a 6-well plate and
allowed to reach 70–80% confluence; a scratch was created using
a p200 pipette tip. Cells were rinsed with PBS and migration was
observed 3 days later. Results in figure 1B suggest that MCF7-Cd
cells display a greater ability to migrate in comparison to parental
MCF7 cells. To confirm the qualitative observations in figure 1B,
a modified Boyden Chamber assay was used to quantify the
difference in cell migration between MCF7 and MCF7-Cd cells
(Fig. 1C). In this assay, 56104 cells (MCF7 or MCF7-Cd) were
plated in the upper chamber and allowed to migrate for 16 hours
through an 8 mM polycarbonate membrane. Cells that have the
ability to migrate and attach to the underside of the membrane
were fixed and stained with crystal violet, and the number of
migrated cells were visualized and counted using a microscope.
Results in figure 1C further demonstrate that cells chronically
exposed to cadmium display an increased ability to migrate (31 vs.
54, p,0.01). The invasive ability of the MCF7-Cd cells was also
investigated using a similar assay, except the membranes in the
chambers were coated with matrigel in order to mimic the
extracellular matrix (Fig. 1D). Again, 56104 cells (MCF7 or
Chronic Cadmium Exposure Promotes SDF-1 Expression
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MCF7-Cd) were added to the upper chamber, and cells with the
ability to invade had to digest the matrigel and attach to the
underside of the chamber. Consistent with the results from the
migration assay, MCF7-Cd cells displayed a greater ability to
digest and invade through the matrigel (48 vs 94, p,0.01).
To understand the molecular alterations that occur in the cells
exposed for prolonged periods to cadmium, clonal cell lines
(MCF7-Cd2 to Cd12) were derived from the pool of MCF7-Cd
cells. After confirming that the cadmium-adapted cell lines
displayed the same characteristics as observed in figure 1–
increased growth, migration and invasion (Fig. S1), we analyzed
the differential gene expression of these cells using both a
metastasis-specific PCR array (Superarray RT-Profiler) and
microarray. Both array studies identified SDF-1, also known as
CXCL12, as being up-regulated in a majority of the cadmium-
adapted cells. Further verification using quantitative RT-PCR
demonstrated that about 70% of the cadmium-adapted cell lines
expressed higher levels of SDF-1 (Fig. 2A), with clones Cd7 and
Cd12 expressing the highest levels. The levels of SDF-1 protein
present in the Cd7 and Cd12 cells and secreted into the media
were also examined using Western blot analysis and ELISA,
respectively. Consistent with the gene expression data, levels of
SDF-1 in both the protein lysates and in the media were elevated,
as shown in figures 2B and C.
Interestingly, SDF-1 has been shown to be an estrogen receptor
(ERa) regulated gene [18]. Since cadmium functions as a
metalloestrogen, we questioned whether cadmium could induce
the expression of SDF-1. To determine if the expression of SDF-1
is regulated by acute cadmium exposure, parental MCF7 cells
were treated with either 1026 M CdCl2 or 10
27 M 17b-estradiol.
Results in figure 3 indicate that both cadmium and estrogen can
increase SDF-1 expression by 6 and 12 fold, respectively (Fig. 3A–
B). Estrogen-induced SDF-1 expression continued to increase for
up to 24 hours, whereas cadmium-induced SDF-1 expression
peaked after 8 hours of exposure. Although, cadmium induction
was not as robust as 17b-estradiol induction, these results clearly
demonstrate that cadmium has the ability to stimulate SDF-1
expression within hours of exposure.
Given that SDF-1 is an ER-target gene, SDF-1 expression was
further analyzed in the Cd-cell lines to see if it was dependent on
ERa by depleting endogenous levels of ERa (Fig. 4). To mediate
ERa silencing (Ei), siRNA was transfected into parental MCF7,
Cd4, Cd7 and Cd12 cells, and the effects of decreased ERa levels
on SDF-1 expression were examined. Cells transfected with
scrambled siRNA were used as controls (Ci). At 48 hours after
transfection, cells were collected for both protein and gene
expression analyses using Western blot and semi-quantitative
RT-PCR, respectively (Fig. 4A–B). Gene expression analysis was
also confirmed by quantitative RT-PCR (qRT-PCR) (Fig. 4C). As
expected, the successful depletion of ERa by siRNA resulted in
lower levels of SDF-1 in parental MCF7 cells. Interestingly, a
similar effect was observed in cells chronically exposed to
Figure 1. Chronic cadmium exposure induces more aggressive cancer phenotypes: cell growth, migration and invasion. (A) MCF7-Cd
cells (black bars) and parental MCF7 cells (white bars) were plated in 6 well plates under hormone-deprived conditions and cell growth was
monitored 2, 4, and 6 days after plating by counting in triplicate. Experimental results are averages of three independent experiments (P,0.01). (B) A
scratch wound assay was used to assess cell migration ability. MCF7 and MCF7-Cd cells were plated in 6-well plates and allowed to reach 70–80%
confluence. A scratch was created using a p-200 pipette tip and a digital image was captured on Day 0. Cells were then allowed to grow and migrate
for 3 days and images of the wound were captured 3 days later. Images are representative of three independent experiments done in triplicates.
Arrows are indicating the same region on the scratch on day 0 and day 3. (C) Modified Boyden chamber assays were performed to measure the
migration abilities of the cells. MCF7 (white bars) and MCF7-Cd (black bars) cells were seeded into upper chambers and cells were allowed to migrate
to lower chamber for 16 hours. Data is representative of 3 independent experiments performed in triplicate (P,0.01). (D) An invasion assay was
performed by seeding either MCF7 (white bars) or MCF7-Cd (black bars) cells in the upper chambers. Cells were allowed to invade through matrigel-
coated membranes for 18 hours. Data is an average of 3 independent experiments done in triplicate (P,0.01).
doi:10.1371/journal.pone.0072639.g001
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cadmium, suggesting that SDF-1 expression in the cadmium-
adapted cells is also dependent on ERa. To determine if ERa
plays a direct role in regulating the transcription of SDF-1, a
luciferase reporter assay was used in the presence and absence of
ERa (Fig. 4E). MCF7, Cd7 and Cd12 cells were transfected with
either a control siRNA (Ci) or one that targets ERa (Ei). The
depletion of ERa, as shown by the Western blot (Fig. 4D),
significantly decreases the transactivation of the SDF-1 promoter
in all three cell lines (Fig. 4E), further establishing the role of ERa
in regulating the expression of SDF-1.
Although SDF-1 is an ERa-regulated gene, it is unclear whether
ERa regulates SDF-1 alone or in collaboration with other
transcription factors. To determine if ERa interacts with other
transcription factors, a co-immunoprecipitation experiment was
used to identify potential transcription factors that may interact
with ERa in cells chronically exposed to cadmium (Fig. 5). Cells
were grown for 48 hours, and cell lysates were precipitated with a-
ERa antibodies. The presence of specific transcription factors in
the immunoprecipitated complexes was determined with Western
blot analysis. Results in figure 5A indicate that a greater fraction of
c-fos and c-jun co-precipitated with ERa in the Cd7 and Cd12
cells when compared to the parental MCF7 (M) cells, whereas
similar levels of Sp-1 and b-catenin– two transcription factors
known to interact with ERa– were found in both parental MCF7
and cadmium-adapted cells (Fig. 5A). Changes in the interaction
of ERa with c-jun and c-fos were further confirmed by reciprocal
co-immunoprecipitation with antibodies against c-jun and c-fos
(Fig. 5B).
Despite the observation that ERa co-precipitates with both c-
jun and c-fos, it is unclear whether these AP-1 transcription factors
are directly involved in the regulation of SDF-1. To understand
the role of c-jun and c-fos in mediating the expression of SDF-1,
the expression of SDF-1 cells was analyzed following siRNA-
mediated silencing of c-jun and c-fos (Fig. 5C). MCF7, Cd7 and
Cd12 cells were transfected with siRNA to target either c-jun (Ji)
or c-fos (Fi), and cells were harvested 48 hours later for Western
blot analysis (Fig. 5C). While lower levels of c-jun and c-fos
resulted in a significant reduction of SDF-1 expression, these lower
levels of c-jun and c-fos apparently led to decreased levels of ERa,
complicating the determination of whether c-jun and c-fos directly
regulate SDF-1 expression.
Since the regulatory region of SDF-1 consists of only one full
ERE site located 234 bp upstream of the promoter, five half ERE
sites located within the proximal promoter, and multiple AP-1 and
Sp-1 sites on the promoter [17], it is probable that ERa may
interact with other transcription factors to regulate SDF-1
expression. Therefore, a chromatin immunoprecipitation (ChIP)
Figure 2. Cells chronically exposed to cadmium express and
secrete higher levels of SDF-1. (A) MCF7 and MCF7-Cd clonal
derivatives (Cd-2, -4, -6, -7, -8, -11 and -12) were plated in 6 well plates
and total RNA was isolated for gene expression analysis using
quantitative PCR. Data is presented as relative SDF-1 fold increases
with MCF7 as the control. (B) SDF-1 protein expression in MCF7, Cd7,
and Cd12 cells was analyzed with Western blot analysis. Actin was used
as a loading control. (C) Conditioned media was collected in the same
experiments shown in B after 24 hours, and the levels of SDF-1 were
measured with an enzyme-linked immunosorbent assay (ELISA). Data is
representative of several experiments done in triplicate (P,0.01).
doi:10.1371/journal.pone.0072639.g002
Figure 3. SDF-1 is induced by acute cadmium and estrogen
exposure. MCF7 cells were hormone deprived and treated with either
1027 M E2 (white bars) or 10
26 M CdCl2 (black bars). Cells were
harvested for gene expression analysis using (A) quantitative and (B)
semi-quantitative RT-PCR. Quantitative PCR data is presented as relative
SDF-1 fold increases.
doi:10.1371/journal.pone.0072639.g003
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assay was used to determine whether a greater fraction of c-jun
and c-fos is recruited to the SDF-1 promoter in cells chronically
exposed to cadmium. Cells were plated for 48 hours and harvested
for ChIP analysis. The recruitment of ERa, c-jun and c-fos was
analyzed by PCR. Results in figures 6A and B indicate that cells
chronically exposed to cadmium (Cd7 and Cd12) had higher levels
Figure 4. SDF-1 expression in cells chronically exposed to cadmium is dependent on ERa. MCF7, Cd4, Cd7 and Cd12 cells were plated in
6-well plates and transfected with either si-ERa (Ei) or si-control (Ci), and collected 48 hours after treatment for protein and gene expression analyses
using (A) Western blot and (B) RT-PCR, respectively. Changes in gene expression were also measured using (C) quantitative RT-PCR, and fold
knockdown was expressed as DCtEi/DCtCi. Fold knockdown of ERa and SDF-1 are represented in white and black, respectively. Data is representative
of at least three independent experiments done in triplicate. GAPDH was used as a control. MCF7, Cd7 and Cd12 were also transfected with siRNA
targeting ERa and the transactivation of the SDF-1 promoter measured using a luciferase reporter assay. Following transfection, cells were collected
for (D) Western blot analysis and (E) reporter gene assay. Data represents at least three independent experiments done in quadruplicate. Actin was
used as a loading control for the Western blot.
doi:10.1371/journal.pone.0072639.g004
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of ERa recruited to the SDF-1 promoter in comparison to
parental MCF7 (M) cells (27% and 47% vs. 15%, respectively).
Similarly, the occupancy of c-jun and c-fos on the SDF-1 promoter
were significantly elevated in Cd7 and Cd12 cells when compared
to parental MCF7 cells, with c-jun showing at least a 2-fold
increase (Fig. 6A–B). The occupancy of all three transcription
factors (ERa, c-jun, and c-fos) were also found elevated in the
cyclin D1 and c-myc promoters of cells chronically exposed to
cadmium (Fig. 6A–B). In contrast, Sp-1 was only found elevated
on the c-myc promoter of cells chronically exposed to cadmium
(Cd7 and 12); no significant difference in Sp-1 levels was observed
on the SDF-1 and cyclin D1 promoters among the different cell
lines (Fig. 6A).
While the results from the ChIP assay strongly support the
notion that ERa, c-jun and c-fos all regulate SDF-1 expression, it
is unclear whether these transcription factors work independently
or together as one regulatory complex. To fully understand the
components of the transcription complex regulating SDF-1
expression, a ChIP re-ChIP assay was performed. Following the
first ChIP assay with either ERa or rabbit IgG as a control, the
DNA-protein complexes were extracted and re-ChIPed with a
second antibody (c-jun, or rabbit IgG). Data from both forward
and reverse ChIP re-ChIP assays display higher levels of ERa/c-
jun complex bound to the SDF-1 promoter in Cd7 and Cd12 cells
when compared to parental MCF-7 cells (Fig. 6C). Since previous
studies have suggested that ERa and c-fos do not interact directly
[19], we evaluated the presence of c-fos in the ERa/c-jun complex
using a triple-ChIP assay (three sequential chromatin IPs), in
which the re-ChIPed DNA containing ERa/c-jun complexes was
immunoprecipitated with a third antibody (c-fos or rabbit IgG) to
verify the presence of c-fos in the complex. Results in figure 6D not
only confirm the occupancy of ERa/c-jun complex on the SDF-1
Figure 5. Prolonged exposure to cadmium enhances the interactions of ERa with c-jun and c-fos. (A) MCF7, Cd7 and Cd12 cell lysates
were immunoprecipitated with either a-ERa or normal rabbit IgG. Proteins interacting with ERa were analyzed with Western blot analysis. (B) Reverse
co-IP was performed with a-c-jun, a-c-fos, or normal rabbit IgG. (C) MCF7, Cd7 and Cd12 were plated in 6-well plates and transfected with siRNA
targeting either c-jun (Ji), c-fos (Fi) or a scramble siRNA control (Ci) and collected 48 hours later for protein analysis.
doi:10.1371/journal.pone.0072639.g005
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promoter, but also demonstrate that c-fos is involved in
transcriptional regulation of SDF-1 in both parental and
cadmium-adapted cell lines.
Discussion
Often referred to as an endocrine disruptor, cadmium is an
environmental contaminant that has been shown to have the
ability to bind to the estrogen receptor and alter the expression of
various estrogen receptor target genes [3,5,8,9]. While epidemi-
ological and animal studies [3,4,6,7,20–23] have implicated
cadmium as a carcinogen, there is no direct evidence suggesting
cadmium promotes breast cancer in humans. Despite this, the
International Agency for Research on Cancer (IARC) has classified
cadmium as a potential human carcinogen. Although multiple
studies– including work from this lab– have demonstrated that
acute cadmium exposures can stimulate breast cancer cell growth
and can activate the estrogen receptor to mediate the expression of
genes associated with cell growth [2,3,5,24–26], less is known
about how chronic exposures of cadmium may contribute to the
Figure 6. ERa, c-fos and c-jun are recruited to SDF-1 promoter. (A) MCF-7, Cd7 and Cd12 cells were harvested for chromatin
immunoprecititation (ChIP) analysis. ChIP analysis was done with a-ERa, a-c-fos, a-c-jun, and a-Sp1, and recruitment of proteins to the SDF-1, cyclin
D1 and c-myc promoters was determined using promoter specific primers and semi-quantitative PCR. (B) Band intensities of PCR products for SDF-1,
cycD, and c-myc were quantified and normalized to input using Quantity One (Bio-Rad) (P,0.001). (C) In the ChIP re-ChIP assay, DNA/protein
complexes from the first ChIP assay were extracted and re-ChIPed with a second antibody. The occupancy of ERa/c-jun or c-Jun/ERa complexes on
the SDF-1 promoter was analyzed as in B (P,0.001). (D) To confirm the presence of c-fos in the ERa/c-jun complex, reChIPed DNA containing ERa/c-
jun complexes were immunoprecipitated with a third antibody, a-c-fos, and the resulting DNA fragments were analyzed as in B (P,0.001).
doi:10.1371/journal.pone.0072639.g006
Chronic Cadmium Exposure Promotes SDF-1 Expression
PLOS ONE | www.plosone.org 8 August 2013 | Volume 8 | Issue 8 | e72639
development and progression of breast cancer. Studies on prostate
cancer and sarcomas have indicated that chronic exposures to
cadmium can be associated with more malignant tumors [10–12].
Additionally, significantly higher levels of cadmium have been
found in breast tumor tissues in comparison to non-tumor tissues
[1,13–16]. The chronic effects of cadmium on the progression of
breast cancer and the molecular alterations induced by cadmium
were never before fully elucidated.
Results from this study confirm that chronic cadmium exposure
promotes the development of more aggressive cancer character-
istics including increased cell growth and an increased ability to
migrate and invade (Fig. 1). To understand the impact of chronic
cadmium exposures at the molecular level, clonal cell lines were
developed from the original MCF7-Cd cell line (MCF7-Cd2 to
12), and it was found that SDF-1, one of the genes identified in
microarray expression analysis, was elevated in more than 70% of
the cadmium-adapted cell lines (Fig. 2A). In addition to expressing
higher levels of SDF-1 at the mRNA level, cells chronically
exposed to cadmium (MCF7-Cd7 and Cd12) also expressed and
secreted more SDF-1 protein into the media (Fig. 2B–C),
consistent with its function as a chemokine, a factor that promotes
cell migration and metastasis [27].
Interestingly, past studies have also demonstrated SDF-1 to be
regulated by ERa [17,18,28]. Consistent with these findings, SDF-
1 mRNA levels were indeed shown to increase within hours of the
cells being treated with 17b-estradiol (Fig. 3A–B). Strikingly, our
results demonstrate that the metalloestrogen, cadmium can also
stimulate SDF-1 gene expression, but to a lesser extent than 17b-
estradiol (6 vs.12 fold, Fig. 3). To establish a link between chronic
cadmium-induced SDF-1 expression and ERa, siRNA was used to
reduce intracellular levels of ERa in parental MCF7, MCF7-Cd4,
-Cd7, and -Cd12 cells. Results showed that depleting ERa
expression subsequently inhibited the expression of SDF-1 in both
MCF7 and cadmium-adapted cells, suggesting that elevated SDF-
1 expression is in part dependent on ERa (Fig. 4). In order to
determine whether ERa regulates the transcription of the SDF-1
gene, a luciferase reporter assay was conducted using SDF1-luc
and co-transfected siRNAs to silence ERa. Results in figure 4E
suggest that depletion of ERa, as indicated by Western blot
analysis (Fig. 4D), significantly reduces transcriptional activation of
the SDF-1 promoter. Similarly, silencing ERa in cadmium-
adapted and parental MCF-7 cells also decreased other ERa
target genes, specifically cyclin D1 and c-myc (Fig. 4). This further
indicates that the estrogen receptor signaling pathway is intact and
may have a heightened response in cells chronically exposed to
cadmium.
To determine if chronic cadmium exposure enhances the
interaction of ERa with other transcription factors, co-immuno-
precipitation experiments were performed. Results in figure 5A
show that a greater fraction of c-jun and c-fos co-precipitated with
ERa in the cadmium-exposed cells. These interactions were
confirmed by reciprocal co-immunoprecipitation (co-IP) with
either c-jun or c-fos (Fig. 5B). While the interaction of ERa with
c-jun is well-documented [8,19,29], the direct interaction between
ERa and c-fos has not been documented. A study by Teyssier
et al. demonstrated that ERa binds directly to c-jun, but not to c-
fos, in pull-down assays [19]. Although our co-IP results show an
ERa/c-fos interaction, it is important to note that this interaction
may be mediated indirectly by c-jun, especially since c-jun and c-
fos often function as heterodimers [30]. Consistent with the results
presented in this study, previous studies have demonstrated that
both cadmium and arsenic can increase the interactions of ERa
with c-jun under acute exposures [8,29].
Though promising, the increased interactions between ERa, c-
jun and c-fos do not prove that these complexes are directly
involved in regulating the expression of SDF-1 in cells chronically
exposed to cadmium. We attempted to show this via siRNA-
mediated silencing of c-jun and c-fos, which did result in a
reduction of SDF-1. Unfortunately, the data could not clearly
demonstrate whether the decrease in SDF-1 was due solely to c-
jun or c-fos since the down regulation of c-jun and c-fos also
decreased endogenous ERa levels, which is already known to
affect SDF-1 levels (Fig. 5C).
To confirm the roles of ERa, c-jun and c-fos in the
transcriptional regulation of SDF-1 in cells chronically exposed
to cadmium, chromatin immunoprecipiation (ChIP) assays were
then used to determine the occupancy status of each transcription
factor on the SDF-1 promoter. In line with previous reports by
Zhu et al. and Boudot et al., our results demonstrate that ERa is
recruited to the SDF-1 promoter [17,28], and the promoter
occupancy by ERa is elevated in cells chronically exposed to
cadmium (Fig. 6A–B). Additionally, a greater fraction of c-jun and
c-fos were also found on the SDF-1, cyclin D1, and c-myc
promoters after chronic cadmium exposure. In contrast, the levels
of transcription factor Sp-1 were only elevated on the c-myc
promoter, suggesting that the cadmium-induced effects are
promoter specific.
Whether ERa regulates the expression of SDF-1 by binding to
classical ERE sites or via interactions with other transcription
factors was uncertain. However, based on the occupancy patterns
of c-jun and c-fos on the SDF-1 promoter, it seemed conceivable
that SDF-1 is regulated in a similar manner as cyclin D1 and c-
myc– both of which are regulated by the interaction of ERa with
c-jun/c-fos heterodimers [31–35]. Since the interaction between
ERa and c-fos is likely mediated indirectly by c-jun [30], further
studies were carried out using both ChIP re-ChIP and triple-ChIP
assays to determine if ERa regulates SDF-1 via interactions with c-
jun/c-fos heterodimer. Data from both forward and reverse ChIP
re-ChIP assays suggested that cells chronically exposed to
cadmium (Cd7 and Cd12) exhibited higher levels of ERa/c-jun
complexes on the SDF-1 promoter (Fig. 6C). The increase in
ERa/c-jun interactions further emphasizes the importance of ERa
and c-jun in regulating SDF-1 expression, especially in cells
chronically exposed to cadmium. Consistent with these results, c-
jun has been shown to regulate SDF-1 expression in other cell
types [36,37]. These new results also mirrored those from our
previous study, which had demonstrated that the ERa/c-jun
interaction was important in modulating the expression of genes in
response to acute cadmium exposure [8]. Interestingly, the ERa/c-
jun interaction has also been shown to be important in cells
exposed to arsenic stress [29], suggesting this may serve as a
common metal-response mechanism.
In summary, this study is the first to demonstrate that chronic
cadmium exposure promotes the acquisition of more aggressive
cancer phenotypes (e.g. growth, migration and invasion) by
stimulating the expression of SDF-1, and altering the molecular
interactions between ERa, and c-jun/c-fos. In essence, our data
suggest that chronic cadmium exposure significantly alters the
molecular dynamics of cells. We speculate that the molecular
interactions of ERa with other transcription factors– including
other members of the AP-1 family, E2F, and NFkB families– are
also affected by chronic cadmium exposure, most likely in a
promoter-specific manner [38,39]. Since estrogen receptor is
known to interact with many coactivators and corepressors
[35,39], it would also be interesting in the future to examine
how chronic cadmium exposure may alter the molecular
interactions between ERa and its coregulators. Additionally, we
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believe that studying the effects of chronic cadmium exposure on
other cell types– both ERa positive and negative– will be crucial
for further understanding cadmium-induced carcinogenesis. The
results presented in this study offer molecular insights into how
mammary tumors that have gradually bioaccumulated significant
levels of cadmium can become more aggressive, and thus
underscore the importance of studying the molecular effects of
chronic cadmium exposure in breast carcinogenesis.
Supporting Information
Figure S1 Cadmium-adapted cells display more aggres-
sive cancer phenotypes: cell growth, migration and
invasion. (A) MCF7-Cd clones (Cd4, Cd7, and Cd12) and
parental MCF7 cells were plated in 6 well plates and growth was
monitored 2, 4, and 6 days after plating by counting in triplicates
with an automatic cell counter (P,0.01). Experimental results are
representative of three independent experiments. (B) Modified-
Boyden chamber assay was performed to measure the migration
abilities of MCF-Cd cells. MCF7 (white bars), Cd7 (gray bars) or
Cd12 (black bars) cells were seeded in upper chamber containing
hormone-deprived media and allowed to migrate for16 hours to
lower chamber containing media contain fetal bovine serum (FBS).
Data is representative of 3 independent experiments done in
triplicates (P,0.01). (C) An invasion assay was performed by
seeding either MCF7 (white bars), Cd7 (gray bars) or Cd12 (black
bars) cells in the upper chamber. Cells were allowed to invade
through matrigel-coated membrane for 18 hours. Data is
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